// App-Quantinova.ai

880 : Mapping the metastatic colorectal cancer phospho-proteome for predicting response to cetuximab

Researchers

Presenter

  • Robin Beekhof

Principal Investigators

  • Mariette Labots

  • Jaco C. Knol

  • Tim R.A. Schelfhorst

  • Nicole van Grieken

  • Sander R. Piersma

  • Thang V. Pham

  • Andrea Bertotti

  • Livio Trusolino

  • Henk M.W. Verheul

  • Connie R. Jimenez

Medical Centers

  • VUmc - OncoProteomics Laboratory, Department of Medical Oncology, Amsterdam, Netherlands

  • VUmc - Department of Medical Oncology, Amsterdam, Netherlands

  • VUmc - Department of Medical Oncology, Amsterdam, Netherlands

  • University of Torino Medical School, Turin, Italy

Locations

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

  • Solid malignancies

  • PDGFRA rearrangement

Biomarkers

  • Dual specificity mitogen-activated protein kinase kinase 1

  • Platelet Derived Growth Factor Receptor Alpha

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Fibroblast growth factor receptor 1

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Erbitux

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final